SOTERA HEALTH CO (SHC) Stock Price, Quote, News and Overview
NASDAQ:SHC - Nasdaq - US83601L1026 - Common Stock - Currency: USD
SHC Quote, Performance and Key Statistics
13.52
0 (0%)
The current stock price of SHC is 13.52 USD. In the past month the price decreased by -1.24%. In the past year, price decreased by -19.57%.
SHC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
| DHR | DANAHER CORP | 28.07 | 151.18B | ||
| A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
| IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
| WAT | WATERS CORP | 31.58 | 22.26B | ||
| ICLR | ICON PLC | 14.39 | 16.63B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
| ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
| RVTY | REVVITY INC | 23.23 | 13.85B | ||
| AVTR | AVANTOR INC | 17.3 | 11.78B | ||
| TEM | TEMPUS AI INC | N/A | 10.72B |
Related stock screener links
About SHC
Company Profile
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The Company’s segments include Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. The Nordion business is a provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and materials industries and for the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.
Company Info
SOTERA HEALTH CO
9100 South Hills Blvd, Suite 300, Suite 300
Broadview Heights OHIO 44147 US
CEO: Michael B. Petras
Employees: 3000
Company Website: https://soterahealth.com/
Investor Relations: https://investors.soterahealth.com/
Phone: 14402621410
SOTERA HEALTH CO / SHC FAQ
What is the stock price of SOTERA HEALTH CO today?
The current stock price of SHC is 13.52 USD.
What is the ticker symbol for SOTERA HEALTH CO stock?
The exchange symbol of SOTERA HEALTH CO is SHC and it is listed on the Nasdaq exchange.
On which exchange is SHC stock listed?
SHC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SOTERA HEALTH CO stock?
13 analysts have analysed SHC and the average price target is 16.38 USD. This implies a price increase of 21.18% is expected in the next year compared to the current price of 13.52. Check the SOTERA HEALTH CO stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SOTERA HEALTH CO worth?
SOTERA HEALTH CO (SHC) has a market capitalization of 3.83B USD. This makes SHC a Mid Cap stock.
How many employees does SOTERA HEALTH CO have?
SOTERA HEALTH CO (SHC) currently has 3000 employees.
What are the support and resistance levels for SOTERA HEALTH CO (SHC) stock?
SOTERA HEALTH CO (SHC) has a support level at 13.44 and a resistance level at 13.57. Check the full technical report for a detailed analysis of SHC support and resistance levels.
Is SOTERA HEALTH CO (SHC) expected to grow?
The Revenue of SOTERA HEALTH CO (SHC) is expected to grow by 5.7% in the next year. Check the estimates tab for more information on the SHC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SOTERA HEALTH CO (SHC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SHC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SHC, evaluating the profitability, health, valuation and growth aspects
- SOTERA HEALTH CO (SHC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SOTERA HEALTH CO (SHC) Sales and EPS estimates to see what analysts future expectations are.
- SOTERA HEALTH CO (SHC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SOTERA HEALTH CO (SHC) Insider and Institutional Ownership to learn about the owners and their transactions.
- SOTERA HEALTH CO (SHC) Stock Chart to make your own analysis
- SOTERA HEALTH CO (SHC) Latest news and press-releases to stay up to date.
Does SOTERA HEALTH CO (SHC) stock pay dividends?
SHC does not pay a dividend.
When does SOTERA HEALTH CO (SHC) report earnings?
SOTERA HEALTH CO (SHC) will report earnings on 2025-02-27, before the market open.
What is the Price/Earnings (PE) ratio of SOTERA HEALTH CO (SHC)?
The PE ratio for SOTERA HEALTH CO (SHC) is 18.03. This is based on the reported non-GAAP earnings per share of 0.75 and the current share price of 13.52 USD. Check the full fundamental report for a full analysis of the valuation metrics for SHC.
What is the Short Interest ratio of SOTERA HEALTH CO (SHC) stock?
The outstanding short interest for SOTERA HEALTH CO (SHC) is 4.94% of its float. Check the ownership tab for more information on the SHC short interest.
SHC Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to SHC. When comparing the yearly performance of all stocks, SHC is a bad performer in the overall market: 73.7% of all stocks are doing better.
SHC Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SHC. SHC has an excellent profitability rating, but there are concerns on its financial health.
SHC Financial Highlights
Over the last trailing twelve months SHC reported a non-GAAP Earnings per Share(EPS) of 0.75. The EPS decreased by -6.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.61% | ||
| ROA | 2.44% | ||
| ROE | 16.33% | ||
| Debt/Equity | 4.91 |
SHC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to SHC. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of -13.58% and a revenue growth 5.7% for SHC